Oxygenta Pharmaceutical Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	1,130	1,093	396.42	309.88	605.25
Other Revenue	2.86	-	-	-0	0
Revenue	1,133	1,093	396.42	309.87	605.25
Revenue Growth (YoY)	3.63%	175.71%	27.93%	-48.80%	16.33%
Cost of Revenue	1,021	1,071	405.89	300.79	564.29
Gross Profit	111.32	21.86	-9.47	9.08	40.96
Selling, General & Admin	76.45	70.52	61.74	60.42	7.87
Other Operating Expenses	185.68	46.67	25.65	19.83	18.33
Operating Expenses	285.36	125.35	113.99	100.77	42.12
Operating Income	-174.03	-103.5	-123.46	-91.69	-1.15
Interest Expense	-47.77	-20.17	-15.81	-14.75	-9.15
Interest & Investment Income	-	0.23	0.18	0.05	0.04
Currency Exchange Gain (Loss)	-	-1.59	0.14	0.13	-
Other Non Operating Income (Expenses)	-	12.21	-0.13	-0.13	-0.1
EBT Excluding Unusual Items	-221.8	-112.82	-139.09	-106.38	-10.36
Gain (Loss) on Sale of Assets	-	0.49	-	-	-
Other Unusual Items	-	-3.2	0.37	-7.34	5.46
Pretax Income	-221.8	-115.53	-138.72	-113.73	-4.89
Income Tax Expense	-46.09	-18.7	-103.92	1.98	1.21
Net Income	-175.72	-96.83	-34.79	-115.71	-6.1
Net Income to Common	-175.72	-96.83	-34.79	-115.71	-6.1
Shares Outstanding (Basic)	37	36	32	14	13
Shares Outstanding (Diluted)	37	36	32	14	13
Shares Change (YoY)	2.91%	12.20%	125.61%	11.43%	-
EPS (Basic)	-4.75	-2.69	-1.09	-8.15	-0.48
EPS (Diluted)	-4.75	-2.69	-1.09	-8.15	-0.48
Free Cash Flow	-406.1	-87.89	-171.55	-112.79	-66.26
Free Cash Flow Per Share	-10.98	-2.44	-5.35	-7.94	-5.20
Gross Margin	9.83%	2.00%	-2.39%	2.93%	6.77%
Operating Margin	-15.37%	-9.47%	-31.14%	-29.59%	-0.19%
Profit Margin	-15.51%	-8.86%	-8.78%	-37.34%	-1.01%
Free Cash Flow Margin	-35.85%	-8.04%	-43.28%	-36.40%	-10.95%
EBITDA	-150.81	-95.34	-96.85	-71.17	14.76
EBITDA Margin	-13.31%	-8.72%	-24.43%	-22.97%	2.44%
D&A For EBITDA	23.23	8.16	26.61	20.52	15.91
EBIT	-174.03	-103.5	-123.46	-91.69	-1.15
EBIT Margin	-15.37%	-9.47%	-31.14%	-29.59%	-0.19%
Revenue as Reported	1,133	1,106	396.85	310.05	605.29

Source: S&P Global Market Intelligence. Standard template. Financial Sources.